Responses
Cardiovascular medicine
Research
Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 2 December 2016
- Published on: 2 December 2016Amazing low use of P2 Y12 inhibitors following ACSShow More
Following ACS (with or without PCI) the use of P2Y12 receptors receptors inhibitors are almost invariable, unless contraindicated absolutely. Use of such drugs only in 49% is exceptionally low, particularly in a regulated health system like that of Finland. There is need to understand why it is so low? Were patients with non- life threatening conditions not put on P2Y12 inhibitors? The study casts more doubts than it solv...
Conflict of Interest:
None declared.